z-logo
Premium
RUNX1 reshapes the epigenetic landscape at the onset of haematopoiesis
Author(s) -
Lichtinger Monika,
Ingram Richard,
Hannah Rebecca,
Müller Dorothee,
Clarke Deborah,
Assi Salam A,
LieALing Michael,
Noailles Laura,
Vijayabaskar M S,
Wu Mengchu,
Tenen Daniel G,
Westhead David R,
Kouskoff Valerie,
Lacaud Georges,
Göttgens Berthold,
Bonifer Constanze
Publication year - 2012
Publication title -
the embo journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.484
H-Index - 392
eISSN - 1460-2075
pISSN - 0261-4189
DOI - 10.1038/emboj.2012.275
Subject(s) - runx1 , haematopoiesis , biology , transcription factor , epigenetics , microbiology and biotechnology , embryonic stem cell , genetics , regulation of gene expression , cancer research , stem cell , gene
Cell fate decisions during haematopoiesis are governed by lineage‐specific transcription factors, such as RUNX1, SCL/TAL1, FLI1 and C/EBP family members. To gain insight into how these transcription factors regulate the activation of haematopoietic genes during embryonic development, we measured the genome‐wide dynamics of transcription factor assembly on their target genes during the RUNX1‐dependent transition from haemogenic endothelium (HE) to haematopoietic progenitors. Using a Runx1−/− embryonic stem cell differentiation model expressing an inducible Runx1 gene, we show that in the absence of RUNX1, haematopoietic genes bind SCL/TAL1, FLI1 and C/EBPβ and that this early priming is required for correct temporal expression of the myeloid master regulator PU.1 and its downstream targets. After induction, RUNX1 binds to numerous de novo sites, initiating a local increase in histone acetylation and rapid global alterations in the binding patterns of SCL/TAL1 and FLI1. The acquisition of haematopoietic fate controlled by Runx1 therefore does not represent the establishment of a new regulatory layer on top of a pre‐existing HE program but instead entails global reorganization of lineage‐specific transcription factor assemblies.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here